Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues
about
Integrating Multiscale Modeling with Drug Effects for Cancer TreatmentOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidLifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeuticsTheory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell KillResistance Development: A Major Piece in the Jigsaw Puzzle of Tumor Size Modeling.Understanding Drug Resistance in Breast Cancer with Mathematical OncologyEvolution of acquired resistance to anti-cancer therapy.Toward a science of tumor forecasting for clinical oncology.Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian CancerImaging mass spectrometry for the precise design of antibody-drug conjugates.Capillary collagen as the physical transport barrier in drug delivery to tumor microenvironment.Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis.Bacterial Carriers for Glioblastoma TherapyCancer Systems Biology: a peek into the future of patient care?Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles.Pathology to enhance precision medicine in oncology: lessons from landscape ecologyStrategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems.An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxiaMultiscale Modeling in the Clinic: Drug Design and DevelopmentThree-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.Modeling drug resistance in a conjoint normal-tumor setting.Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors.Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma.Assessing similarity among individual tumor size lesion dynamics: The CICIL methodology.Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies.A novel individual-cell-based mathematical model based on multicellular tumour spheroids for evaluating doxorubicin-related delivery in avascular regions.Evaluating the influence of mechanical stress on anticancer treatments through a multiphase porous media model.Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches.Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer.Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy.Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling.
P2860
Q26770510-2E708342-2182-4DEA-8BAF-08982DB61C85Q26799981-F1BA017D-D6CA-44B5-A9DA-7C0B34F015C8Q28543966-32060E2D-8E2D-4C06-AA89-6EB6FEB9BB2DQ28550211-CE6A663E-1999-43BD-949A-DF114F82C945Q33361224-58716C73-B434-45CE-9023-A774623812A6Q33690336-5DB489C7-673A-4FD4-9D92-82CC15502DC4Q33758382-D001FC13-AEE4-4165-B4B3-F7DB16FA9AF7Q35178358-8BC5CB06-3435-4880-B206-E72375CE96C0Q35882323-B237F2D9-3C4E-4F54-88C9-2DACB0275FF5Q35995175-F1F86A12-7B7A-41FD-A143-CB2763330BBDQ36072635-3E0C94A3-63BC-4839-936D-01759659EFCDQ36791673-E5ECB92D-41D3-4EE2-85E9-5EF0621A70CDQ37411899-1F327C24-F7A7-4A7A-BD16-39F829235D56Q37718566-20F503BB-C5AC-4187-ACEA-9C7343AB2571Q38184909-A855AC20-77DA-4179-A553-E71339A3D745Q38248809-C1037C45-6D6C-40F7-BC56-8B70E5EC6D1DQ38518699-898C01A7-6412-450D-97A4-3EEB0D573E71Q38586234-1EDC5CA2-22DA-4406-866C-AD7BD26ED625Q38685879-14E3B36F-4180-4C6D-944C-0F1A211A3934Q38736948-2DE40078-F261-4970-83BA-978F94AD97A3Q39044851-2EDFC614-68B2-40DF-B95F-1DC39B23FE66Q40599449-5796A86F-AB27-460A-B49B-A48880562B7FQ40626318-3B2AA8C7-2236-49E9-8D5F-DAAFDE07CF39Q47297973-CD6469EB-F20E-44CD-AC4A-016C84C2269FQ47553750-503D2113-D8BD-4E0E-B584-A0B95E813F93Q47554623-45AA2B22-BE20-4C90-BF93-F3784D13AA8CQ47804226-39073A56-586A-4516-BF39-02C14DB5BC74Q47893798-E95BD806-6CF8-45AA-BAD0-0E1DB66C2EFDQ47978622-9A1B1A5D-A483-48BE-BABE-36F118125465Q50103495-C6242191-0130-4340-86F0-D37FC52B2466Q51348764-5F363847-27C7-4030-8CDB-9401575B0480Q52576799-C92378E0-DF46-4715-AC8E-9033EE0AE687Q52608753-E596A90C-7804-496C-BECB-9A5C8B4A1C30Q52684332-890AF78B-A2E4-4F89-8D8D-5E30557A9BD0
P2860
Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Current advances in mathematic ...... penetration into tumor tissues
@ast
Current advances in mathematic ...... penetration into tumor tissues
@en
Current advances in mathematic ...... penetration into tumor tissues
@nl
type
label
Current advances in mathematic ...... penetration into tumor tissues
@ast
Current advances in mathematic ...... penetration into tumor tissues
@en
Current advances in mathematic ...... penetration into tumor tissues
@nl
prefLabel
Current advances in mathematic ...... penetration into tumor tissues
@ast
Current advances in mathematic ...... penetration into tumor tissues
@en
Current advances in mathematic ...... penetration into tumor tissues
@nl
P2860
P3181
P356
P1476
Current advances in mathematic ...... penetration into tumor tissues
@en
P2093
Katarzyna A Rejniak
P2860
P3181
P356
10.3389/FONC.2013.00278
P407
P577
2013-11-18T00:00:00Z